Feverfew fights inflammation - Brief Article

Parthenolide, the active ingredient in the herb feverfew, appears to inhibit the pro-inflammatory signaling pathway by binding to the protein IKK-beta, according to a study published in the journal Chemistry and Biology. Researchers at Yale University say that their results may be useful in the development of a new class of anti-inflammatory drugs that are safer and more effective than the "original natural product."

Feverfew, or Tanacetum parthenium, is a member of the aster family; it has been used for centuries to treat migraine headaches and fever and for external pain relief. The herb is available fresh or in capsules or tincture. Temporary side effects may include oral ulcers, inflammation or swelling, and loss of taste.

COPYRIGHT 2002 Weider Publications
COPYRIGHT 2001 Gale Group